IFP Advisors Inc Has $375,000 Stake in CME Group Inc. (CME)
IFP Advisors Inc increased its position in CME Group Inc. (NASDAQ:CME) by 2.4% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,998 shares of the financial services provider’s stock after buying an additional 71 shares during the period. IFP Advisors Inc’s holdings in CME Group were worth $375,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in CME. RMB Capital Management LLC boosted its position in CME Group by 3.1% in the first quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock valued at $13,642,000 after buying an additional 3,501 shares during the period. Profund Advisors LLC boosted its position in CME Group by 4.2% in the first quarter. Profund Advisors LLC now owns 11,222 shares of the financial services provider’s stock valued at $1,333,000 after buying an additional 457 shares during the period. Thrivent Financial For Lutherans boosted its position in CME Group by 5.6% in the first quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock valued at $1,485,000 after buying an additional 660 shares during the period. Parsons Capital Management Inc. RI acquired a new position in CME Group during the first quarter valued at about $569,000. Finally, Dowling & Yahnke LLC boosted its position in CME Group by 1.7% in the first quarter. Dowling & Yahnke LLC now owns 6,844 shares of the financial services provider’s stock valued at $813,000 after buying an additional 114 shares during the period. 83.25% of the stock is currently owned by institutional investors and hedge funds.
Shares of CME Group Inc. (NASDAQ CME) opened at 125.92 on Wednesday. The stock has a market capitalization of $42.80 billion, a PE ratio of 25.70 and a beta of 0.73. The company has a 50-day moving average price of $123.49 and a 200 day moving average price of $121.06. CME Group Inc. has a 52 week low of $98.95 and a 52 week high of $127.96.
CME Group (NASDAQ:CME) last issued its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm had revenue of $925 million during the quarter, compared to analyst estimates of $931.05 million. During the same period last year, the company earned $1.14 EPS. CME Group’s quarterly revenue was up 2.1% compared to the same quarter last year. Equities analysts forecast that CME Group Inc. will post $4.81 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.10%. The ex-dividend date of this dividend is Thursday, September 7th. CME Group’s dividend payout ratio is currently 53.99%.
WARNING: This story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.watchlistnews.com/ifp-advisors-inc-has-375000-stake-in-cme-group-inc-cme/1493377.html.
Several research firms have recently issued reports on CME. UBS AG reissued a “buy” rating and set a $134.00 target price (down from $136.00) on shares of CME Group in a research note on Monday, June 5th. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Keefe, Bruyette & Woods reissued a “hold” rating and set a $127.00 target price on shares of CME Group in a research note on Friday, July 14th. BidaskClub cut CME Group from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Finally, Deutsche Bank AG reduced their target price on CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a research note on Tuesday, July 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $131.63.
In other CME Group news, Director Timothy S. Bitsberger sold 800 shares of the firm’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $125.93, for a total transaction of $100,744.00. Following the transaction, the director now directly owns 9,024 shares in the company, valued at approximately $1,136,392.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Bryan T. Durkin sold 9,200 shares of the firm’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total value of $1,151,196.00. Following the transaction, the president now owns 70,938 shares in the company, valued at $8,876,471.94. The disclosure for this sale can be found here. Insiders have sold a total of 91,085 shares of company stock valued at $11,242,896 over the last three months. 0.61% of the stock is owned by corporate insiders.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.